NanoGenics  Ltd

NanoGenics is an innovative, research-based biotechnology company leading the development of artificial viruses to deliver gene therapy. Our mission is to overcome the challenge of delivery to allow the full potential of gene therapy to be realised. To achieve this vision, NanoGenics is developing a series of in-house products using the LipTide platform across a range of disease areas from cancer to cystic fibrosis. Our lead product will enter clinical trials in 2020.